Stifel Financial Corp Sqz Biotechnologies CO Transaction History

Stifel Financial Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.27 - $0.68 $6,157 - $15,508	-22,806 Reduced 2.61%	851,520 $229,000
Q1 2023 May 12, 2023	SELL	$0.53 - $0.87 $85,452 - $140,271	-161,232 Reduced 15.57%	874,326 $489,000
Q4 2022 Feb 13, 2023	BUY	$0.67 - $2.85 $365,385 - $1.55 Million	545,352 Added 111.25%	1,035,558 $766,000
Q3 2022 Nov 14, 2022	BUY	$2.16 - $3.48 $54,375 - $87,605	25,174 Added 5.41%	490,206 $1.12 Million
Q2 2022 Aug 15, 2022	BUY	$2.77 - $5.0 $803,474 - $1.45 Million	290,063 Added 165.78%	465,032 $1.48 Million
Q1 2022 May 13, 2022	BUY	$4.01 - $10.42 $701,625 - $1.82 Million	174,969 New	174,969 $842,000

1.47M

Ticker SQZ
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,248,600
Market Cap $1.46M
Description
SQZ Biotechnologies Company, a clinical-stage biotechnology company, develops cell therapies for patients with cancer, autoimmune, infectious diseases, and other serious conditions. Its lead product candidate is SQZ-PBMC-HPV, from its SQZ Antigen Presenting Cells platform, which is in a Phase I clinical trial as a monotherapy and in combination ...

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Stifel Financial Corp with notifications on news.